These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

563 related items for PubMed ID: 18410975

  • 1. Pulsed dose rate brachytherapy as the sole adjuvant radiotherapy after breast-conserving surgery of T1-T2 breast cancer: first long time results from a clinical study.
    Johansson B, Karlsson L, Liljegren G, Hardell L, Persliden J.
    Radiother Oncol; 2009 Jan; 90(1):30-5. PubMed ID: 18410975
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Partial breast irradiation in breast conserving therapy by way of intersitial brachytherapy.
    Benitez PR, Chen PY, Vicini FA, Wallace M, Kestin L, Edmundson G, Gustafson G, Martinez A.
    Am J Surg; 2004 Oct; 188(4):355-64. PubMed ID: 15474426
    [Abstract] [Full Text] [Related]

  • 6. 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer.
    Harms W, Krempien R, Hensley FW, Berns C, Fritz P, Wannenmacher M.
    Strahlenther Onkol; 2002 Nov; 178(11):607-14. PubMed ID: 12426671
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer.
    Kaufman SA, DiPetrillo TA, Price LL, Midle JB, Wazer DE.
    Brachytherapy; 2007 Nov; 6(4):286-92. PubMed ID: 17991625
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial.
    Kauer-Dorner D, Pötter R, Resch A, Handl-Zeller L, Kirchheiner K, Meyer-Schell K, Dörr W.
    Radiother Oncol; 2012 Jan; 102(1):96-101. PubMed ID: 21907439
    [Abstract] [Full Text] [Related]

  • 14. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
    Póti Z, Nemeskéri C, Fekésházy A, Sáfrány G, Bajzik G, Nagy ZP, Bidlek M, Sinkovics I, Udvarhelyi N, Liszkay G, Repa I, Galuska L, Trón L, Mayer A, Esik O.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1022-33. PubMed ID: 15001241
    [Abstract] [Full Text] [Related]

  • 15. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
    Trombetta M, Julian T, Bhandari T, Werts ED, Miften M, Parda D.
    Brachytherapy; 2008 Mar 15; 7(1):29-36. PubMed ID: 18201940
    [Abstract] [Full Text] [Related]

  • 16. Long-term outcome with interstitial brachytherapy boost in the treatment of women with early-stage breast cancer.
    Neumanova R, Petera J, Frgala T, Dusek L, Jarkovsky J, Kuricka R.
    Neoplasma; 2007 Mar 15; 54(5):413-23. PubMed ID: 17688371
    [Abstract] [Full Text] [Related]

  • 17. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
    Chao KK, Vicini FA, Wallace M, Mitchell C, Chen P, Ghilezan M, Gilbert S, Kunzman J, Benitez P, Martinez A.
    Int J Radiat Oncol Biol Phys; 2007 Sep 01; 69(1):32-40. PubMed ID: 17467920
    [Abstract] [Full Text] [Related]

  • 18. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial.
    Polgár C, Fodor J, Orosz Z, Major T, Takácsi-Nagy Z, Mangel LC, Sulyok Z, Somogyi A, Kásler M, Németh G.
    Strahlenther Onkol; 2002 Nov 01; 178(11):615-23. PubMed ID: 12426672
    [Abstract] [Full Text] [Related]

  • 19. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M, Julian TB, Werts DE, McWilliams W, Kim Y, Miften M, Parda D.
    Am J Clin Oncol; 2009 Jun 01; 32(3):314-8. PubMed ID: 19451803
    [Abstract] [Full Text] [Related]

  • 20. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial.
    Polgár C, Sulyok Z, Fodor J, Orosz Z, Major T, Takácsi-Nagy Z, Mangel LC, Somogyi A, Kásler M, Németh G.
    J Surg Oncol; 2002 Jul 01; 80(3):121-8; discussion 129. PubMed ID: 12115793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.